<p>Cardiol Therapeutics Inc.（TSE:CRDL - 获取免费报告）的股票在周一交易中下跌了 14.6%。该公司的股价最低曾达到 C$1.24，最后交易价为 C$1.29。在午盘交易中，约有 551,069 股成交，较平均每日成交量 108,983 股增加了 406%。该股票此前收盘价为 C$1.51。</p>
<p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
<h2>Cardiol Therapeutics 股票表现</h2>
<p>该公司的 50 日简单移动平均线为 C$1.50，200 日简单移动平均线为 C$1.65。公司的流动比率为 2.49，速动比率为 6.84，债务与股本比率为 1.59。公司的市值为 C$1.29 亿，市盈率为-3.15，贝塔值为 1.31。</p>
<p>Cardiol Therapeutics（TSE:CRDL - 获取免费报告）最近于 11 月 13 日（星期四）发布了其财报。该公司报告本季度每股收益为 C($0.12)。整体来看，研究分析师预计 Cardiol Therapeutics Inc.在当前财政年度将发布每股收益-0.49。</p>
<h2>关于 Cardiol Therapeutics</h2>
<p>（获取免费报告）</p>
<p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家临床阶段的生命科学公司，专注于抗炎和抗纤维化疗法的研究与临床开发，以治疗心脏病。公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，并正在进行临床开发，用于治疗心脏病。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Cardiol Therapeutics</li>
<li>比较和交易高市盈率股票</li>
<li>国会再次超越市场——这是他们购买的三只股票</li>
<li>拥有债券的风险</li>
<li>与三只顶级零售 ETF 一起购物</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>如果 D-Wave 风险太大，考虑这三只量子 ETF 进行多样化投资</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Cardiol Therapeutics 吗？</h2>
<p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Cardiol Therapeutics 并不在名单上。</p>
<p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

CRDL

<p>Cardiol Therapeutics (TSE:CRDL) 的股价下跌了 14.6%，至 1.29 加元，交易量较平均水平上升了 406%。该股票的 50 日移动平均价为 1.50 加元，200 日平均价为 1.65 加元。公司报告的季度每股收益为 C($0.12)，专注于开发心脏病治疗方案。分析师目前对该股票的评级为持有，建议其他股票可能是更好的投资选择</p>

<p>Shares of Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) were down 14.6% during trading on Monday . The company traded as low as C$1.24 and last traded at C$1.29. Approximately 551,069 shares traded hands during mid-day trading, an increase of 406% from the average daily volume of 108,983 shares. The stock had previously closed at C$1.51.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc.（TSE:CRDL - 获取免费报告）的股票在周一交易中下跌了 14.6%。该公司的股价最低曾达到 C$1.24，最后交易价为 C$1.29。在午盘交易中，约有 551,069 股成交，较平均每日成交量 108,983 股增加了 406%。该股票此前收盘价为 C$1.51。</p>
</div><p>Get <strong>Cardiol Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
</div><h2>Cardiol Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>Cardiol Therapeutics 股票表现</h2>
</div><p>The firm's 50-day simple moving average is C$1.50 and its two-hundred day simple moving average is C$1.65. The company has a current ratio of 2.49, a quick ratio of 6.84 and a debt-to-equity ratio of 1.59. The company has a market cap of C$129.00 million, a PE ratio of -3.15 and a beta of 1.31.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 C$1.50，200 日简单移动平均线为 C$1.65。公司的流动比率为 2.49，速动比率为 6.84，债务与股本比率为 1.59。公司的市值为 C$1.29 亿，市盈率为-3.15，贝塔值为 1.31。</p>
</div><p>Cardiol Therapeutics (TSE:CRDL - Get Free Report) last released its earnings results on Thursday, November 13th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, research analysts anticipate that Cardiol Therapeutics Inc. will post -0.49 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Cardiol Therapeutics（TSE:CRDL - 获取免费报告）最近于 11 月 13 日（星期四）发布了其财报。该公司报告本季度每股收益为 C($0.12)。整体来看，研究分析师预计 Cardiol Therapeutics Inc.在当前财政年度将发布每股收益-0.49。</p>
</div><h2>About Cardiol Therapeutics</h2>
<div class="lb-trans"><h2>关于 Cardiol Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家临床阶段的生命科学公司，专注于抗炎和抗纤维化疗法的研究与临床开发，以治疗心脏病。公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，并正在进行临床开发，用于治疗心脏病。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Cardiol Therapeutics</li>
<li>Comparing and Trading High PE Ratio Stocks</li>
<li>Congress Beat the Market Again—Here Are the 3 Stocks They Bought</li>
<li>The Risks of Owning Bonds</li>
<li>Go on a Shopping Spree With 3 Top Retail ETFs</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>If D-Wave Is Too Risky, Consider These 3 Quantum ETFs for Diversification</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Cardiol Therapeutics</li>
<li>比较和交易高市盈率股票</li>
<li>国会再次超越市场——这是他们购买的三只股票</li>
<li>拥有债券的风险</li>
<li>与三只顶级零售 ETF 一起购物</li>
<li>罗素 2000 指数，投资者如何利用它进行盈利交易</li>
<li>如果 D-Wave 风险太大，考虑这三只量子 ETF 进行多样化投资</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardiol Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Cardiol Therapeutics 吗？</h2>
</div><p>Before you consider Cardiol Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Cardiol Therapeutics 并不在名单上。</p>
</div><p>While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Cardiol Therapeutics (TSE:CRDL) 股价下跌 14.6% - 以下是原因